Pharmatest´s CEO, Jukka Rissanen, is attending the BIO International Convention 2026, taking place in San Diego, June 22–25, 2026. The event is the world’s largest biotechnology gathering, bringing together over 20,000 industry professionals from across the globe.

The BIO International Convention serves as a key meeting point for the global biotech community, providing a platform to reconnect around the shared goal of advancing science to improve lives. It brings together stakeholders across the entire ecosystem—including pharmaceutical companies, biotech startups, academia, investors, and public organizations—to foster collaboration and drive innovation in drug development and public health.

“At this year’s BIO International Convention, one message stands out above all others: innovation needs purpose. In drug development, technology and speed move us forward, but purpose provides direction. Ultimately, innovation matters only if it improves patients’ lives.”

– Jukka Rissanen

Pharmatest specializes in high-quality preclinical solutions, with particular expertise in oncology and musculoskeletal diseases. Participation in BIO 2026 supports the company’s commitment to strengthening partnerships and exploring new collaboration opportunities within the international life sciences community.

During the event, Pharmatest looks forward to meeting both existing and potential partners. Meetings can be scheduled via the BIO Partnering™ platform:

https://partner.bio.org/conference/86/search/71139?isShared=true